P56.99
BillableHydrops fetalis due to other hemolytic disease
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is P56.99 an HCC code?
Yes. P56.99 maps to Hemolytic and Aplastic Anemias under the CMS-HCC V28 risk adjustment model.
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for P56.99
For P56.99 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed P56.99 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
P56.99 is the ICD-10-CM diagnosis code for hydrops fetalis due to other hemolytic disease. Severe fluid accumulation throughout a newborn's body caused by red blood cells being destroyed due to a hemolytic disease other than the common blood type incompatibilities. P56.99 sits in the ICD-10-CM chapter for certain conditions originating in the perinatal period (p00-p96), within the section covering hemorrhagic and hematological disorders of newborn (p50-p61).
Under the CMS-HCC V28 risk adjustment model, P56.99 maps to Hemolytic and Aplastic Anemias (HCC 109) with a community, non-dual, aged base RAF weight of 0.291. P56.99 was not retained as a payment HCC under the older V24 model, so V28 introduced or recategorized it during the 2024–2026 phase-in. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Use this code when hydrops fetalis is due to hemolytic disease that is not isoimmunization-related; document the specific cause in the medical record. Because P56.99 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for P56.99 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use this code when hydrops fetalis is due to hemolytic disease that is not isoimmunization-related; document the specific cause in the medical record
- •Consider other causes such as infections, hereditary conditions, or other blood group incompatibilities
Clinical Significance
Hydrops fetalis due to other specified hemolytic diseases represents severe systemic fluid accumulation from identified hemolytic causes other than standard isoimmunization, requiring emergency intervention and intensive care. This condition carries extremely high morbidity and mortality risk despite having a specified underlying hemolytic etiology.
Documentation Requirements
- ✓Clinical evidence of generalized edema and fluid accumulation
- ✓Documentation of specific hemolytic disease causing hydrops
- ✓Laboratory confirmation of severe anemia and hemolysis
- ✓Imaging studies showing systemic fluid accumulation
- ✓Identification of specific hemolytic etiology (not ABO/Rh)
- ✓Assessment of cardiovascular compromise and heart failure
- ✓Treatment plan addressing both hydrops and underlying hemolysis
- ✓Specialized neonatal intensive care coordination